Vaxcell-Bio Therapeutics (323990 KS)

Analysis

Health Care • South Korea

Vaxcell-Bio Therapeutics, Co. Ltd operates pharmaceutical development businesses. The Company develops anti-cancer drugs, cellular drugs, immune drugs, and other medicines. Vaxcell-Bio Therapeutics conducts businesses in South Korea.

Refresh

Request Primer

No publications yet

No AI primers are available right now. Create one using Smartkarma AI.

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00